The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.
Peter Gøtzsche gives advice on what withdrawal symptoms may look like and explains the dangers of—and alternatives to—forced treatment.
Withdraw from psychiatric drugs at your own speed—according to what you feel. Don’t reduce again before you feel stabilised on the previous dose.
Psychiatrists have made hundreds of millions of people dependent on psychiatric drugs and yet have done virtually nothing to find out how to help the patients come off them again.
Very few doctors know anything about withdrawal and make horrible mistakes. If they taper at all, they do it far too quickly because the few guidelines that exist recommend far too quick tapering.
Anti-stigma campaigns reinforce a belief that people with mental health issues must have treatment and thus, push discussion of withdrawal and negative aspects of psychiatric drugs into anonymous spaces.
Online communities are stepping in to help people facing withdrawal effects amass information and receive support for their withdrawal experiences.
Medically-induced harm—affecting tens of millions of people worldwide—has taken the field decades to take seriously.
If academic psychiatry is evidence-based, why did it take two decades to recognize SSRI withdrawal as widespread and chronic among patients?
Peter Gøtzsche and Anders Sørensen on trying to get a review of methods for safe antidepressant withdrawal published in Cochrane: "They sent us on a mission that was impossible to accomplish" to "protect the psychiatric guild."
Published in the peer-reviewed journal Advances in Mind Body Medicine, this case series is the first of its kind to document the methodology employed in the successful discontinuation of a range of psychotropic medications, with holistic support interventions providing long-term mood support.
My study, in which I slowly withdrew people from prescribed antipsychotics and antidepressants, found that it is possible to decrease both spending on psychiatric drugs and patients' chronic exposure to them. In general, the drug-reduction process was well-tolerated and well-accepted among those treated.
The message in journal editorials, comments and opinion articles, is that 'this new study shows great promise' and that 'we need further research'. My interpretation is: 'give us the money and we will be happy to carry this out'. With the implied promise that, once this new research has been done, we will get a better world. Sadly this is rarely ever the case.
The New Yorker's story on Laura Delano and psychiatric drug withdrawal is a glass-half-full story: It addresses a problem in psychiatry and yet hides the deeper story to be told. A story of how her recovery resulted from seeing herself within a counter-narrative that tells of the harm that psychiatry can do.
The patient experiencing the pain of withdrawal believed that they would feel better when they stopped taking their antidepressants. After all, they’re under the care of a board-certified medical professional who has vowed to do no harm. But despite those reassurances, they find themselves in a world of hurt.
Antidepressant withdrawal is no longer an unknown disorder since knowledge on this topic has grown enough to be translated into practice. As proposed by George Engel in 1977, medical doctors, including psychiatrists, can observe and listen to their patients and develop a program to treat withdrawal and restore health.
Psychiatric meds can shut down the emotions and consciousness enough to make it possible to tolerate dynamics that would inspire rage or surges of empowered activity without the meds. It can be helpful to look closely at these blocks and start to create a map to freedom, understanding that it is a complex process that involves not only the physiology of the body of the individual taking meds, but the architecture of the social system around that person.
It's been over 5 years since I started offering non-medical consultations to people in the process of coming off or hoping to come off psych drugs. I wanted to share here some things I have learned in this process. Despite how far we have come, we have a long way to go in the quest to liberate all who wish to be liberated from psychiatry.
With increasing evidence that psychiatric drugs do more harm than good over the long term, the field of psychiatry often seems focused on sifting through the mounds of research data it has collected, eager to at last sit up and cry, here’s a shiny speck of gold! Our drugs do work! One recently published study on withdrawal of antipsychotics tells of long-term benefits. A second tells of long-term harm. Which one is convincing?
H. 3594 would require pharmacists to distribute pamphlets containing information on benzodiazepine misuse and abuse, risk of dependency and addiction, handling and addiction treatment resources. This would be a major legislative response to the prescribing patterns for these drugs today.
We held the first course ever on psychiatric drug withdrawal on 12 June 2017 in Copenhagen. The course was open to patients, relatives, psychologists, doctors and other social and healthcare workers, and 77 people participated.
After long-term use, most people are going to have serious symptoms when stopping SSRIs. Many people are going to have transient, mild to moderate difficulty and some are going to end up falling down the akathisia rabbit hole. That is a long, difficult drop.